Venture Catalysts Exits Pee Safe with 9.60x Investment Gain
The secondary component of the funding round enabled liquidity for early investors, including Venture Catalysts, allowing them to convert long-term investments into cash returns.
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
Venture Catalysts has announced a full exit from Pee Safe, delivering a 9.60x return and an XIRR of 30.53 percent. The exit comes after Pee Safe raised USD 32 million in a funding round led by OrbiMed.
The secondary component of the funding round enabled liquidity for early investors, including Venture Catalysts, allowing them to convert long-term investments into cash returns.
Pee Safe, founded in 2013 by Vikas Bagaria and Srijana Bagaria, focuses on personal hygiene and wellness products. Its portfolio includes toilet seat sanitizers, sanitary pads, menstrual cups, intimate washes, and grooming products. Venture Catalysts first invested in the company in 2017.
The exit, completed in January 2026, highlights the firm’s approach of identifying early-stage opportunities and guiding them toward growth and eventual liquidity. Pee Safe has expanded significantly over the years, with its products now available in more than 50,000 retail outlets across over 100 cities, along with a strong presence on e-commerce and quick commerce platforms.
Apoorva Ranjan Sharma said, “This exit is a validation of patient early stage investing where we back founders before the market agrees. Pee Safe built category depth, distribution muscle, and brand trust.”
Pee Safe’s founder Vikas Bagaria added, “Venture Catalysts believed in our mission early and were part of our first fund raise. As we welcome OrbiMed and scale faster, we are proud that early partners can realize meaningful outcomes.”
The latest funding round takes Pee Safe’s total funding to USD 45.55 million, with investors such as Zerodha and Natco Pharma continuing their association.
Venture Catalysts has announced a full exit from Pee Safe, delivering a 9.60x return and an XIRR of 30.53 percent. The exit comes after Pee Safe raised USD 32 million in a funding round led by OrbiMed.
The secondary component of the funding round enabled liquidity for early investors, including Venture Catalysts, allowing them to convert long-term investments into cash returns.
Pee Safe, founded in 2013 by Vikas Bagaria and Srijana Bagaria, focuses on personal hygiene and wellness products. Its portfolio includes toilet seat sanitizers, sanitary pads, menstrual cups, intimate washes, and grooming products. Venture Catalysts first invested in the company in 2017.
The exit, completed in January 2026, highlights the firm’s approach of identifying early-stage opportunities and guiding them toward growth and eventual liquidity. Pee Safe has expanded significantly over the years, with its products now available in more than 50,000 retail outlets across over 100 cities, along with a strong presence on e-commerce and quick commerce platforms.
Apoorva Ranjan Sharma said, “This exit is a validation of patient early stage investing where we back founders before the market agrees. Pee Safe built category depth, distribution muscle, and brand trust.”
Pee Safe’s founder Vikas Bagaria added, “Venture Catalysts believed in our mission early and were part of our first fund raise. As we welcome OrbiMed and scale faster, we are proud that early partners can realize meaningful outcomes.”
The latest funding round takes Pee Safe’s total funding to USD 45.55 million, with investors such as Zerodha and Natco Pharma continuing their association.
